Pleasanton, CA, United States of America

Michael R Love

This inventor holds 72 USPTO granted patents and 58 published patent applications and 36 EPO patents, primarily in Analyte Monitoring Systems (CPC class A61B). Top assignees: Abbott Diabetes Care Inc., Lifescan Corporation. Active years: 1995-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael R Love. Retrieved from https://idiyas.com/inventor/michael-r-love

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 72 (Patent Applications = 58)

% Patents Active = 98.6

EPO Patents = 36 (Patent Applications = 57)

Average Co-Inventor Count = 5.6

ph-index = 20

Forward Citations = 1,524(Granted Patents)

Forward Citations (Not Self Cited) = 1,038(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Detroit, MI (US) (1995)
Pleasanton, CA (US) (1999 - 2023)

Company Filing History:

70 out of 1,450

Abbott Diabetes Care Inc.

where one patent can have more than one assignee

Years Active: 1995-2026

Loading Chart...

Areas of Expertise:

Analyte Sensor

Medical Devices

Wireless Communication

Temperature Compensation

Device Management

Health Management

Dynamic Glucose Profile

Energy Efficiency

RF Detection

Insertion Processes

Displays

Self-Powered Devices

72 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12605185 - Medical device inserters and processes of inserting and using medical devices (2026-04-21),

2. 12569173 - Analyte sensor and apparatus for insertion of the sensor (2026-03-10),

3. 12535478 - Systems, devices, and methods for wireless communications in analyte monitoring systems (2026-01-27),

4. 12482558 - Medical devices and methods (2025-11-25),

5. 12440173 - Displays for a medical device (2025-10-14),

6. 12440172 - Displays for a medical device (2025-10-14),

7. 12440126 - Temperature-compensated analyte monitoring devices, systems, and methods thereof (2025-10-14),

8. 12411930 - Application interface and display control in an analyte monitoring environment (2025-09-09),

9. 12379340 - Systems, devices, and methods for RF detection of analyte sensor measurements (2025-08-05),

10. 12350041 - Systems, devices, and methods for energy efficient electrical device activation (2025-07-08),

11. 12323492 - Management of multiple devices within an analyte monitoring environment (2025-06-03),

12. 12315630 - Medical devices and methods (2025-05-27),

13. 12310757 - System, device and method of dynamic glucose profile response to physiological parameters (2025-05-27),

14. 12290354 - Temperature-compensated analyte monitoring devices, systems, and methods thereof (2025-05-06),

15. 11835479 - Systems, devices, and methods for RF detection of analyte sensor measurements (2023-12-05),

Title: The Innovative Mind of Michael R Love

Introduction: Michael R Love, a talented inventor based in Pleasanton, California, is known for his groundbreaking contributions to the field of technology and beyond.

Latest Patents: Michael R Love has recently been granted several patents for his innovative creations, including a cutting-edge software application that revolutionizes data analysis in the healthcare industry.

Career Highlights: With a career spanning over two decades, Michael R Love has established himself as a visionary in the tech world. His work has not only earned him recognition but has also significantly impacted various sectors, from finance to telecommunications.

Collaborations: Throughout his career, Michael R Love has collaborated with leading tech companies and research institutions to bring his ideas to life. His ability to work seamlessly with teams has led to the successful development of numerous groundbreaking products.

Conclusion: Michael R Love's passion for innovation and his relentless drive to push boundaries have solidified his position as a prominent figure in the world of inventions. His work continues to inspire and shape the future of technology.

Profile summary based on public USPTO records.